MYTX-011
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MYTX-011, covering 2025-12-16 to 2025-12-16. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer [Phase 1]